DNA damage responsive microRNAs misexpressed in human cancer modulate therapy sensitivity.
Ontology highlight
ABSTRACT: The DNA damage response (DDR) is activated upon DNA damage and prevents accumulation of mutations and chromosomal rearrangements, both driving carcinogenesis. Tumor cells often have defects in the DDR, which in combination with continuous cell proliferation are exploited by genotoxic cancer therapies. Most cancers, overcome initial sensitivity and develop drug resistance, e.g. by modulation of the DDR. Not much is known, however, about DNA damage responsive microRNAs in cancer therapy resistance. Therefore, we mapped temporal microRNA expression changes in primary breast epithelial cells upon low and high dose exposure to the DNA damaging agents ionizing radiation and cisplatin. A third of all DDR microRNAs commonly regulated across all treatments was also misexpressed in breast cancer, in
SUBMITTER: van Jaarsveld MT
PROVIDER: S-EPMC4685152 | biostudies-literature | 2014 May
REPOSITORIES: biostudies-literature
ACCESS DATA